An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Bringing next-gen cannabinoid therapeutics to cancer patients
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Both manufacturing facilities are based out of Benguluru, India
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
The new program includes upstream and downstream process development and large-scale GMP production.
New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
Subscribe To Our Newsletter & Stay Updated
